Contribution of the IBD5 locus to Crohn's disease in the Swedish population

References

• Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003; 124: 521–36
   PubMed Web of Science ®Google Scholar
• Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005; 6: 376–88
   PubMed Web of Science ®Google Scholar
• Askling J, Grahnquist L, Ekbom A, Finkel Y. Incidence of paediatric Crohn's disease in Stockholm, Sweden. Lancet 1999; 354: 1179
   PubMed Web of Science ®Google Scholar
• Lapidus A, Bernell O, Hellers G, Persson PG, Lofberg R. Incidence of Crohn's disease in Stockholm County 1955–1989. Gut 1997; 41: 480–6
   PubMed Web of Science ®Google Scholar
• Lapidus A. Crohn's disease in Stockholm County during 1990–2001: an epidemiological update. World J Gastroenterol 2006; 12: 75–81
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M., Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of nod2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
   PubMed Web of Science ®Google Scholar
• Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes Immun 2004; 5: 417–25
   PubMed Web of Science ®Google Scholar
• Helio T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52: 558–62
   PubMed Web of Science ®Google Scholar
• Törkvist L, Noble C, Lördal M, Sjöqvist U, Lindforss U, Nimmo E, et al. Contribution of CARD15 variants in determining susceptibility to Crohn's disease in Sweden. Scand J Gastroenterol 2006; 41: 700–5
   PubMed Web of Science ®Google Scholar
• Vind I, Vieira A, Hougs L, Tavares L, Riis L, Andersen PS, et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype–phenotype analysis in Danish and Portuguese patients and controls. Digestion 2005; 72: 156–63
   PubMed Web of Science ®Google Scholar
• Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925–8
   PubMed Web of Science ®Google Scholar
• Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122: 854–66
   PubMed Web of Science ®Google Scholar
• Ma Y, Ohmen JD, Li Z, Bentley LG, McElree C, Pressman S, et al. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis 1999; 5: 271–8
   PubMed Web of Science ®Google Scholar
• Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, et al. A Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863–70
   PubMed Web of Science ®Google Scholar
• Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223–8
   PubMed Web of Science ®Google Scholar
• Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229–32
   PubMed Web of Science ®Google Scholar
• Noble CL, Nimmo ER, Drummond H, Ho GT, Tenesa A, Smith L, et al. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 2005; 129: 1854–64
   PubMed Web of Science ®Google Scholar
• Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36: 471–5
   PubMed Web of Science ®Google Scholar
• Torok HP, Glas J, Tonenchi L, Lohse P, Muller-Myhsok B, Limbersky O, et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 2005; 54: 1421–7
   PubMed Web of Science ®Google Scholar
• Russell, RK, Drummond, H, Nimmo, E, Anderson, N, Noble, C, Wilson, D, , et al. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth parameters in early-onset inflammatory bowel disease. Gut 2006;55:1114–23.
   PubMed Web of Science ®Google Scholar
• Waller S, Tremelling M, Bredin F, Godfrey L, Howson J, Parkes M. Evidence for Association of OCTN Genes and IBD5 with ulcerative colitis. Gut 2006; 55: 809–14
   PubMed Web of Science ®Google Scholar
• Armuzzi A, Ahmad T, Ling KL, de Silva A, Cullen S, van Heel D, et al. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 2003; 52: 1133–9
   PubMed Web of Science ®Google Scholar
• Mirza MM, Fisher SA, King K, Cuthbert AP, Hampe J, Sanderson J, et al. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet 2003; 72: 1018–22
   PubMed Web of Science ®Google Scholar
• Newman B, Gu X, Wintle R, Cescon D, Yazdanpanah M, Liu X, et al. A risk haplotype in the solute carrier family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 2005; 128: 260–9
   PubMed Web of Science ®Google Scholar
• Palmieri O, Latiano A, Valvano R, D'Inca R, Vecchi M, Sturniolo GC, et al. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2006; 23: 497–506
   PubMed Web of Science ®Google Scholar
• Vermeire S, Pierik M, Hlavaty T, Claessens G, van Schuerbeeck N, Joossens S, et al. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology 2005; 129: 1845–53
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; Suppl 170: 2–6
   Web of Science ®Google Scholar
• Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8–15
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
   PubMed Web of Science ®Google Scholar
• Giallourakis C, Stoll M, Miller K, Hampe J, Lander ES, Daly MJ, et al. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 2003; 73: 205–11
   PubMed Web of Science ®Google Scholar
• Tosa M, Negoro K, Kinouchi Y, Abe H, Nomura E, Takagi S, et al. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease. Scand J Gastroenterol 2006; 41: 48–53
   PubMed Web of Science ®Google Scholar
• Lohoff M, Mak TW. Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat Rev Immunol 2005; 5: 125–35
   PubMed Web of Science ®Google Scholar
• Clavell M, Correa-Gracian H, Liu Z, Craver R, Brown R, Schmidt-Sommerfeld E, et al. Detection of interferon regulatory factor-1 in lamina propria mononuclear cells in Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 30: 43–7
   PubMed Web of Science ®Google Scholar
• Forcione DG, Rosen MJ, Kisiel JB, Sands BE. Anti-Saccharomyces Cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 2004; 53: 1117–22
   PubMed Web of Science ®Google Scholar
• Urcelay E, Mendoza JL, Martinez A, Fernandez L, Taxonera C, Diaz-Rubio M, et al. IBD5 Polymorphisms in inflammatory bowel disease: association with response to Infliximab. World J Gastroenterol 2005; 11: 1187–92
   PubMed Web of Science ®Google Scholar